Thendor Therapeutics Inc.
Lexington, SC
- UEI
- Q9D5S4TLQG21
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 317 Ruth Vista Rd, Lexington, SC 29073, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| TT-036 for the treatment of scleroderma-associated pulmonary fibrosis - abstract fibroproliferative illnesses leading to… | National Heart Lung and Blood Institute | $389,754 |
Quick answers
What is Thendor Therapeutics Inc.'s UEI?
Thendor Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is Q9D5S4TLQG21.
Where is Thendor Therapeutics Inc. located?
Thendor Therapeutics Inc.'s physical address in SAM.gov is 317 Ruth Vista Rd, Lexington, SC 29073, USA.
Is Thendor Therapeutics Inc. registered in SAM.gov?
Yes. Thendor Therapeutics Inc.'s SAM.gov registration is active through August 3, 2027.
What is Thendor Therapeutics Inc.'s most recent federal award?
Thendor Therapeutics Inc.'s most recent federal grant award is TT-036 for the treatment of scleroderma-associated pulmonary fibrosis - abstract fibroproliferative illnesses leading to… (R41HL176277), from National Heart Lung and Blood Institute, on September 5, 2024.
On GovTribe
See Thendor Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors